BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32146472)

  • 1. Adverse Effects of Autoclaved Diets on the Progression of Chronic Kidney Disease and Chronic Kidney Disease-Mineral Bone Disorder in Rats.
    Biruete A; Srinivasan S; O'Neill KD; Vorland CJ; Hill Gallant KM; Cai W; Uribarri J; Johnston N; Allen MR; Chen NX; Moe SM
    Am J Nephrol; 2020; 51(5):381-389. PubMed ID: 32146472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rat model of chronic kidney disease-mineral bone disorder.
    Moe SM; Chen NX; Seifert MF; Sinders RM; Duan D; Chen X; Liang Y; Radcliff JS; White KE; Gattone VH
    Kidney Int; 2009 Jan; 75(2):176-84. PubMed ID: 18800026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney Disease Progression Does Not Decrease Intestinal Phosphorus Absorption in a Rat Model of Chronic Kidney Disease-Mineral Bone Disorder.
    Vorland CJ; Biruete A; Lachcik PJ; Srinivasan S; Chen NX; Moe SM; Hill Gallant KM
    J Bone Miner Res; 2020 Feb; 35(2):333-342. PubMed ID: 31618470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetylcysteine (NAC), an anti-oxidant, does not improve bone mechanical properties in a rat model of progressive chronic kidney disease-mineral bone disorder.
    Allen MR; Wallace J; McNerney E; Nyman J; Avin K; Chen N; Moe S
    PLoS One; 2020; 15(3):e0230379. PubMed ID: 32203558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Advanced Glycation End-Products (AGE) Lowering Drug ALT-711 on Biochemical, Vascular, and Bone Parameters in a Rat Model of CKD-MBD.
    Chen NX; Srinivasan S; O'Neill K; Nickolas TL; Wallace JM; Allen MR; Metzger CE; Creecy A; Avin KG; Moe SM
    J Bone Miner Res; 2020 Mar; 35(3):608-617. PubMed ID: 31743501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ferric citrate and intravenous iron sucrose on markers of mineral, bone, and iron homeostasis in a rat model of CKD-MBD.
    Biruete A; Metzger CE; Chen NX; Swallow EA; Vrabec C; Clinkenbeard EL; Stacy AJ; Srinivasan S; O'Neill K; Avin KG; Allen MR; Moe SM
    Nephrol Dial Transplant; 2022 Sep; 37(10):1857-1867. PubMed ID: 35482713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary Protein Intake and Bone Across Stages of Chronic Kidney Disease.
    Stremke ER; Biruete A; Hill Gallant KM
    Curr Osteoporos Rep; 2020 Jun; 18(3):247-253. PubMed ID: 32240477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel chronic kidney disease mouse model to evaluate the progression of hyperphosphatemia and associated mineral bone disease.
    Tani T; Orimo H; Shimizu A; Tsuruoka S
    Sci Rep; 2017 May; 7(1):2233. PubMed ID: 28533541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ovariectomy on the progression of chronic kidney disease-mineral bone disorder (CKD-MBD) in female Cy/+ rats.
    Vorland CJ; Lachcik PJ; Swallow EA; Metzger CE; Allen MR; Chen NX; Moe SM; Hill Gallant KM
    Sci Rep; 2019 May; 9(1):7936. PubMed ID: 31138895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth performance and physiological parameters of conventional and specified pathogen-free rats fed autoclaved diets with different protein sources.
    Barszcz M; Paradziej-Łukowicz J; Taciak M; Tuśnio A; Staśkiewicz Ł; Muszyńska-Furas B; Lewandowska A; Pastuszewska B; Skomiał J
    J Anim Physiol Anim Nutr (Berl); 2015 Dec; 99(6):1116-26. PubMed ID: 25475549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Energy-Dense Diets and Mineral Metabolism in the Context of Chronic Kidney Disease⁻Metabolic Bone Disease (CKD-MBD).
    Rodriguez M; Aguilera-Tejero E
    Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of fibroblast growth factor 23 in chronic kidney disease-mineral and bone disorder.
    Diniz H; Frazão JM
    Nefrologia; 2013 Nov; 33(6):835-44. PubMed ID: 24158124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.
    Neven E; Vervaet B; Brand K; Gottwald-Hostalek U; Opdebeeck B; De Maré A; Verhulst A; Lalau JD; Kamel S; De Broe ME; D'Haese PC
    Kidney Int; 2018 Jul; 94(1):102-113. PubMed ID: 29716795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Dietary Fiber Inulin Slows Progression of Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD) in a Rat Model of CKD.
    Biruete A; Chen NX; Metzger CE; Srinivasan S; O'Neill K; Fallen PB; Fonseca A; Wilson HE; de Loor H; Evenepoel P; Swanson KS; Allen MR; Moe SM
    JBMR Plus; 2023 Dec; 7(12):e10837. PubMed ID: 38130753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Dietary Fermentable Fiber Inulin Alters the Intestinal Microbiome and Improves Chronic Kidney Disease Mineral-Bone Disorder in a Rat Model of CKD.
    Biruete A; Chen NX; Metzger CE; Srinivasan S; Oâ Neill K; Fallen PB; Fonseca A; Wilson HE; de Loor H; Evenepoel P; Swanson KS; Allen MR; Moe SM
    bioRxiv; 2023 Jan; ():. PubMed ID: 36778372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. R-568 reduces ectopic calcification in a rat model of chronic kidney disease-mineral bone disorder (CKD-MBD).
    Moe SM; Seifert MF; Chen NX; Sinders RM; Chen X; Duan D; Henley C; Martin D; Gattone VH
    Nephrol Dial Transplant; 2009 Aug; 24(8):2371-7. PubMed ID: 19258382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid suppression therapy normalizes chronic kidney disease-induced elevations in cortical bone vascular perfusion: a pilot study.
    Aref MW; Swallow EA; Metzger CE; Chen N; Moe SM; Allen MR
    Osteoporos Int; 2019 Aug; 30(8):1693-1698. PubMed ID: 31069439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe chronic kidney disease environment reduced calcium-sensing receptor expression in parathyroid glands of adenine-induced rats even without high phosphorus diet.
    Uchiyama T; Ohkido I; Nakashima A; Saito Y; Okabe M; Yokoo T
    BMC Nephrol; 2020 Jun; 21(1):219. PubMed ID: 32517664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying advanced glycation end products as a major source of oxidants in aging: implications for the management and/or prevention of reduced renal function in elderly persons.
    Vlassara H; Uribarri J; Ferrucci L; Cai W; Torreggiani M; Post JB; Zheng F; Striker GE
    Semin Nephrol; 2009 Nov; 29(6):594-603. PubMed ID: 20006791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.